Impact of Protein Glycosylation on Lipoprotein Metabolism and Atherosclerosis.

Protein glycosylation is a post-translational modification consisting of the enzymatic attachment of carbohydrate chains to specific residues of the protein sequence. Several types of glycosylation have been described, with N-glycosylation and O-glycosylation being the most common types impacting on crucial biological processes, such as protein synthesis, trafficking, localization, and function. Genetic defects in genes involved in protein glycosylation may result in altered production and activity of crucial proteins, with a broad range of clinical manifestations, including dyslipidemia and atherosclerosis. A large number of apolipoproteins, lipoprotein receptors, and other proteins involved in lipoprotein metabolism are glycosylated, and alterations in their glycosylation profile are associated with changes in their expression and/or function. Rare genetic diseases and population genetics have provided additional information linking protein glycosylation to the regulation of lipoprotein metabolism.

[1]  E. Stroes,et al.  Common gene variants in ASGR1 gene locus associate with reduced cardiovascular risk in absence of pleiotropic effects. , 2020, Atherosclerosis.

[2]  D. Rader,et al.  Novel congenital disorder of O-linked glycosylation caused by GALNT2 loss of function. , 2020, Brain : a journal of neurology.

[3]  D. Lefeber,et al.  Reduced CETP glycosylation and activity in patients with homozygous B4GALT1 mutations , 2019, Journal of inherited metabolic disease.

[4]  L. Al-Gazali,et al.  Endoplasmic reticulum quality control of LDLR variants associated with familial hypercholesterolemia , 2019, FEBS open bio.

[5]  A. Avan,et al.  Scavenger receptor Class B type I as a potential risk stratification biomarker and therapeutic target in cardiovascular disease , 2019, Journal of cellular physiology.

[6]  C. Lebrilla,et al.  Site-Specific Glycoprofiles of HDL-Associated ApoE are Correlated with HDL Functional Capacity and Unaffected by Short-Term Diet. , 2019, Journal of proteome research.

[7]  Richard G. Lee,et al.  ApoC-III Glycoforms Are Differentially Cleared by Hepatic TRL (Triglyceride-Rich Lipoprotein) Receptors. , 2019, Arteriosclerosis, thrombosis, and vascular biology.

[8]  N. Seidah,et al.  Hypolipidaemia among patients with PMM2-CDG is associated with low circulating PCSK9 levels: a case report followed by observational and experimental studies , 2019, Journal of Medical Genetics.

[9]  D. Rader,et al.  N-Glycosylation Defects in Humans Lower Low-Density Lipoprotein Cholesterol Through Increased Low-Density Lipoprotein Receptor Expression , 2019, Circulation.

[10]  G. Norata,et al.  Immunometabolic function of cholesterol in cardiovascular disease and beyond. , 2019, Cardiovascular research.

[11]  A. Orekhov,et al.  Glycosylation of human plasma lipoproteins reveals a high level of diversity, which directly impacts their functional properties. , 2019, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[12]  G. Norata,et al.  Biological Consequences of Dysfunctional HDL. , 2019, Current medicinal chemistry.

[13]  G. Norata,et al.  Lysosomal Acid Lipase: From Cellular Lipid Handler to Immunometabolic Target. , 2019, Trends in pharmacological sciences.

[14]  K. Linton,et al.  Identification of CD36 as a new interaction partner of membrane NEU1: potential implication in the pro-atherogenic effects of the elastin receptor complex , 2018, Cellular and Molecular Life Sciences.

[15]  I. Gudelj,et al.  Immunoglobulin G glycosylation in aging and diseases. , 2018, Cellular immunology.

[16]  A. Fox-Robichaud,et al.  Sialidase down-regulation reduces non-HDL cholesterol, inhibits leukocyte transmigration, and attenuates atherosclerosis in ApoE knockout mice , 2018, The Journal of Biological Chemistry.

[17]  A. Annoni,et al.  Myeloid apolipoprotein E controls dendritic cell antigen presentation and T cell activation , 2018, Nature Communications.

[18]  D. Girelli,et al.  Sialylated isoforms of apolipoprotein C-III and plasma lipids in subjects with coronary artery disease , 2018, Clinical chemistry and laboratory medicine.

[19]  N. Seidah,et al.  Site-specific O-glycosylation of members of the low-density lipoprotein receptor superfamily enhances ligand interactions , 2018, The Journal of Biological Chemistry.

[20]  Xian-cheng Jiang,et al.  Phospholipid transfer protein: its impact on lipoprotein homeostasis and atherosclerosis , 2018, Journal of Lipid Research.

[21]  Khoa Nguyen,et al.  Targeted Measurements of O- and N-Glycopeptides Show That Proteins in High Density Lipoprotein Particles Are Enriched with Specific Glycosylation Compared to Plasma. , 2017, Journal of proteome research.

[22]  Honglin Li,et al.  Functional Metabolomics Characterizes a Key Role for N-Acetylneuraminic Acid in Coronary Artery Diseases , 2017, Circulation.

[23]  D. Rader,et al.  New insights into the role of glycosylation in lipoprotein metabolism , 2017, Current opinion in lipidology.

[24]  A. Orekhov,et al.  Chemical composition of circulating native and desialylated low density lipoprotein: what is the difference? , 2017 .

[25]  A. Chabowski,et al.  The role of CD36 receptor in the pathogenesis of atherosclerosis. , 2017, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

[26]  A. Zwinderman,et al.  Apolipoprotein C-III Levels and Incident Coronary Artery Disease Risk: The EPIC-Norfolk Prospective Population Study , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[27]  J. Danesh,et al.  ANGPTL3 Deficiency and Protection Against Coronary Artery Disease. , 2017, Journal of the American College of Cardiology.

[28]  D. Legrand,et al.  TMEM165 deficiencies in Congenital Disorders of Glycosylation type II (CDG-II): Clues and evidences for roles of the protein in Golgi functions and ion homeostasis. , 2017, Tissue & cell.

[29]  A. Parikh,et al.  HDL Glycoprotein Composition and Site-Specific Glycosylation Differentiates Between Clinical Groups and Affects IL-6 Secretion in Lipopolysaccharide-Stimulated Monocytes , 2017, Scientific Reports.

[30]  D. Neumann,et al.  Post-translational modifications of CD36 (SR-B2): Implications for regulation of myocellular fatty acid uptake. , 2016, Biochimica et biophysica acta.

[31]  B. Nordestgaard,et al.  Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology , 2016, Journal of Lipid Research.

[32]  A. Orekhov,et al.  Carbohydrate composition of circulating multiple-modified low-density lipoprotein , 2016, Vascular health and risk management.

[33]  Christopher D. Brown,et al.  Loss of Function of GALNT2 Lowers High-Density Lipoproteins in Humans, Nonhuman Primates, and Rodents. , 2016, Cell metabolism.

[34]  Sumitra Govindarajan,et al.  Plasma Myeloperoxidase and Total Sialic Acid as Prognostic Indicators in Acute Coronary Syndrome. , 2016, Journal of clinical and diagnostic research : JCDR.

[35]  D. Gudbjartsson,et al.  Variant ASGR1 Associated with a Reduced Risk of Coronary Artery Disease. , 2016, The New England journal of medicine.

[36]  D. Billheimer,et al.  Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetes1[S] , 2016, Journal of Lipid Research.

[37]  Dajiang J. Liu,et al.  Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease , 2016, Science.

[38]  A. Hoischen,et al.  TMEM199 Deficiency Is a Disorder of Golgi Homeostasis Characterized by Elevated Aminotransferases, Alkaline Phosphatase, and Cholesterol and Abnormal Glycosylation. , 2016, American journal of human genetics.

[39]  A. Hoischen,et al.  CCDC115 Deficiency Causes a Disorder of Golgi Homeostasis with Abnormal Protein Glycosylation. , 2016, American journal of human genetics.

[40]  M. Goran,et al.  The Association of Human Apolipoprotein C-III Sialylation Proteoforms with Plasma Triglycerides , 2015, PloS one.

[41]  C. Lebrilla,et al.  Combined High-Density Lipoprotein Proteomic and Glycomic Profiles in Patients at Risk for Coronary Artery Disease. , 2015, Journal of proteome research.

[42]  G. Norata,et al.  Apolipoprotein C-III: From Pathophysiology to Pharmacology. , 2015, Trends in pharmacological sciences.

[43]  G. Norata,et al.  HDL in infectious diseases and sepsis. , 2015, Handbook of experimental pharmacology.

[44]  L. Badimón,et al.  Glycoproteome of human apolipoprotein A-I: N- and O-glycosylated forms are increased in patients with acute myocardial infarction. , 2014, Translational research : the journal of laboratory and clinical medicine.

[45]  W. Harris,et al.  Reduced Apolipoprotein Glycosylation in Patients with the Metabolic Syndrome , 2014, PloS one.

[46]  B. Nordestgaard,et al.  Loss-of-function mutations in APOC3 and risk of ischemic vascular disease. , 2014, The New England journal of medicine.

[47]  He Zhang,et al.  Loss-of-function mutations in APOC3, triglycerides, and coronary disease. , 2014, The New England journal of medicine.

[48]  N. Seidah,et al.  Low Density Lipoprotein Receptor Class A Repeats Are O-Glycosylated in Linker Regions* , 2014, The Journal of Biological Chemistry.

[49]  M. Bamshad,et al.  Solving glycosylation disorders: fundamental approaches reveal complicated pathways. , 2014, American journal of human genetics.

[50]  C. Lebrilla,et al.  Glycomic Analysis of High Density Lipoprotein Shows a Highly Sialylated Particle , 2014, Journal of proteome research.

[51]  J. Jaeken Glycosylation and its Disorders: General Overview , 2014 .

[52]  C. Spahr,et al.  Recombinant human lecithin‐cholesterol acyltransferase Fc fusion: Analysis of N‐ and O‐linked glycans and identification and elimination of a xylose‐based O‐linked tetrasaccharide core in the linker region , 2013, Protein science : a publication of the Protein Society.

[53]  Fei Zhao,et al.  Glycosyltransferase GLT8D2 Positively Regulates ApoB100 Protein Expression in Hepatocytes , 2013, International journal of molecular sciences.

[54]  B. Trigatti,et al.  Hypomorphic sialidase expression decreases serum cholesterol by downregulation of VLDL production in mice , 2012, Journal of Lipid Research.

[55]  D. Sahoo,et al.  Functional Characterization of Newly-Discovered Mutations in Human SR-BI , 2012, PloS one.

[56]  P. Nilsson,et al.  Combined effects of brachial pulse pressure and sialic acid for risk of cardiovascular events during 40 years of follow-up in 37 843 individuals , 2012, Journal of hypertension.

[57]  Kathryn M. Spitler,et al.  O-GlcNAcylation and oxidation of proteins: is signalling in the cardiovascular system becoming sweeter? , 2012, Clinical science.

[58]  Kelley W. Moremen,et al.  Vertebrate protein glycosylation: diversity, synthesis and function , 2012, Nature Reviews Molecular Cell Biology.

[59]  H. Wandall,et al.  Probing isoform-specific functions of polypeptide GalNAc-transferases using zinc finger nuclease glycoengineered SimpleCells , 2012, Proceedings of the National Academy of Sciences.

[60]  Sander Kersten,et al.  Regulation of triglyceride metabolism by Angiopoietin-like proteins. , 2012, Biochimica et biophysica acta.

[61]  J. Albers,et al.  Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism. , 2012, Biochimica et biophysica acta.

[62]  A. Zwinderman,et al.  Heterozygosity for a loss-of-function mutation in GALNT2 improves plasma triglyceride clearance in man. , 2011, Cell metabolism.

[63]  G. Norata,et al.  HDLs, immunity, and atherosclerosis , 2011, Current opinion in lipidology.

[64]  H. Kennedy,et al.  Impact of site-specific N-glycosylation on cellular secretion, activity and specific activity of the plasma phospholipid transfer protein. , 2011, Biochimica et biophysica acta.

[65]  M. Hayden,et al.  Novel mutations in scavenger receptor BI associated with high HDL cholesterol in humans , 2011, Clinical genetics.

[66]  C. Des Rosiers,et al.  Acute Regulation of Cardiac Metabolism by the Hexosamine Biosynthesis Pathway and Protein O-GlcNAcylation , 2011, PloS one.

[67]  E. Bennett,et al.  O-Glycosylation Modulates Proprotein Convertase Activation of Angiopoietin-like Protein 3 , 2010, The Journal of Biological Chemistry.

[68]  Tanya M. Teslovich,et al.  Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.

[69]  M. Raftery,et al.  Glycosylation and Sialylation of Macrophage-derived Human Apolipoprotein E Analyzed by SDS-PAGE and Mass Spectrometry , 2010, Molecular & Cellular Proteomics.

[70]  D. Drucker,et al.  Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36. , 2009, Gastroenterology.

[71]  K. Linton,et al.  The Human Scavenger Receptor CD36 , 2009, The Journal of Biological Chemistry.

[72]  R. Collins,et al.  Common variants at 30 loci contribute to polygenic dyslipidemia , 2009, Nature Genetics.

[73]  M. Goodarzi,et al.  Changes in sialylation of low‐density lipoprotein in coronary artery disease , 2008 .

[74]  R. Collins,et al.  Newly identified loci that influence lipid concentrations and risk of coronary artery disease , 2008, Nature Genetics.

[75]  Gert Matthijs,et al.  Impaired glycosylation and cutis laxa caused by mutations in the vesicular H+-ATPase subunit ATP6V0A2 , 2008, Nature Genetics.

[76]  E. Sarandöl,et al.  Sialic acid and oxidizability of lipid and proteins and antioxidant status in patients with coronary artery disease , 2007, Cell biochemistry and function.

[77]  D. Rader,et al.  Hepatic proprotein convertases modulate HDL metabolism. , 2007, Cell metabolism.

[78]  Z. Serdar,et al.  The relation between oxidant and antioxidant parameters and severity of acute coronary syndromes , 2007, Acta cardiologica.

[79]  J. Marth,et al.  Glycosylation in Cellular Mechanisms of Health and Disease , 2006, Cell.

[80]  S. Qu,et al.  N-Glycosylation is Required for Secretion-Competent Human Plasma Phospholipid Transfer Protein , 2006, The protein journal.

[81]  T. Hennet,et al.  Congenital disorder of glycosylation (CDG) Ig: Report on a patient and review of the literature , 2005, Journal of Inherited Metabolic Disease.

[82]  T. Manabe,et al.  Direct targeting of human plasma for matrix‐assisted laser desorption/ionization and analysis of plasma proteins by time of flight‐mass spectrometry , 2005, Electrophoresis.

[83]  T. Hayakawa,et al.  Site-specific glycosylation analysis of human apolipoprotein B100 using LC/ESI MS/MS. , 2005, Glycobiology.

[84]  W. Dobyns,et al.  Olivopontocerebellar atrophy leading to recognition of carbohydrate-deficient glycoprotein syndrome type I , 1996, Journal of Neurology.

[85]  M. Krieger,et al.  Identification of the N-Linked Glycosylation Sites on the High Density Lipoprotein (HDL) Receptor SR-BI and Assessment of Their Effects on HDL Binding and Selective Lipid Uptake* , 2003, The Journal of Biological Chemistry.

[86]  R. McLeod,et al.  The N-linked oligosaccharides at the amino terminus of human apoB are important for the assembly and secretion of VLDL DOI 10.1194/jlr.M200077-JLR200 , 2002, Journal of Lipid Research.

[87]  P. Rudd,et al.  Structural Elucidation of the N- andO-Glycans of Human Apolipoprotein(a) , 2001, The Journal of Biological Chemistry.

[88]  A. Munnich,et al.  A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases , 2001, Journal of medical genetics.

[89]  H. Gylling,et al.  Sialic acid content of low density lipoprotein and its relation to lipid concentrations and metabolism of low density lipoprotein and cholesterol. , 2000, Journal of lipid research.

[90]  T. Mazzone,et al.  Transport and Processing of Endogenously Synthesized ApoE on the Macrophage Cell Surface* , 2000, The Journal of Biological Chemistry.

[91]  P. Marmillot,et al.  Desialylation of human apolipoprotein E decreases its binding to human high-density lipoprotein and its ability to deliver esterified cholesterol to the liver. , 1999, Metabolism: clinical and experimental.

[92]  J. Chambers,et al.  Plasma sialic acid and coronary artery atheromatous load in patients with stable chest pain. , 1999, Atherosclerosis.

[93]  J. Kaski,et al.  Serum sialic acid concentration is not associated with the extent or severity of coronary artery disease in patients with stable angina pectoris. , 1998, American heart journal.

[94]  M. Jauhiainen,et al.  Biosynthesis and secretion of human plasma phospholipid transfer protein. , 1998, Journal of lipid research.

[95]  N. Davidson,et al.  Inhibition of N-linked glycosylation results in retention of intracellular apo[a] in hepatoma cells, although nonglycosylated and immature forms of apolipoprotein[a] are competent to associate with apolipoprotein B-100 in vitro. , 1998, Journal of lipid research.

[96]  M. Passarelli,et al.  Lipoprotein desialylation simultaneously enhances the cell cholesterol uptake and impairs the reverse cholesterol transport system: in vitro evidences utilizing neuraminidase-treated lipoproteins and mouse peritoneal macrophages. , 1998, Atherosclerosis.

[97]  R. Dwek,et al.  Concepts and principles of O-linked glycosylation. , 1998, Critical reviews in biochemistry and molecular biology.

[98]  K. Adeli,et al.  Conformational changes in apolipoprotein B modulate intracellular assembly and degradation of ApoB-containing lipoprotein particles in HepG2 cells. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[99]  M. Tremblay,et al.  Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions. , 1997, Journal of lipid research.

[100]  V. Tertov,et al.  Metabolism of native and naturally occurring multiple modified low density lipoprotein in smooth muscle cells of human aortic intima. , 1997, Experimental and molecular pathology.

[101]  N. Packer,et al.  Desialylated LDL uptake in human and mouse macrophages can be mediated by a lectin receptor. , 1996, Atherosclerosis.

[102]  Xavier Collet,et al.  Site‐specific detection and structural characterization of the glycosylation of human plasma proteins lecithin:cholesterol acyltransferase and apolipoprotein D using HPLC/electrospray mass spectrometry and sequential glycosidase digestion , 1995, Protein science : a publication of the Protein Society.

[103]  R. Hammer,et al.  Asialoglycoprotein receptor deficiency in mice lacking the minor receptor subunit. , 1994, The Journal of biological chemistry.

[104]  Terri L. Gilbert,et al.  Complete cDNA encoding human phospholipid transfer protein from human endothelial cells. , 1994, The Journal of biological chemistry.

[105]  F. Paillard,et al.  LDL sialic acid content in patients with coronary artery disease. , 1993, Clinica chimica acta; international journal of clinical chemistry.

[106]  R. Mcleod,et al.  Lecithin:cholesterol acyltransferase: role of N-linked glycosylation in enzyme function. , 1993, The Biochemical journal.

[107]  A. Tall,et al.  Human plasma cholesteryl ester transfer protein consists of a mixture of two forms reflecting variable glycosylation at asparagine 341. , 1993, Biochemistry.

[108]  A. Varki,et al.  Biological roles of oligosaccharides: all of the theories are correct , 1993, Glycobiology.

[109]  J. Hoeg,et al.  O-linked glycosylation modifies the association of apolipoprotein A-II to high density lipoproteins. , 1993, The Journal of biological chemistry.

[110]  V. Tertov,et al.  Carbohydrate composition of protein and lipid components in sialic acid-rich and -poor low density lipoproteins from subjects with and without coronary artery disease. , 1993, Journal of lipid research.

[111]  V. Tertov,et al.  Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[112]  V. Tertov,et al.  Sialic acid content of human low density lipoproteins affects their interaction with cell receptors and intracellular lipid accumulation. , 1992, Journal of lipid research.

[113]  L. Råstam,et al.  Serum Sialic Acid Concentration Predicts both Coronary Heart Disease and Stroke Mortality: Multivariate Analysis Including 54385 Men and Women during 20.5 Years Follow-up , 1992 .

[114]  K. Takeshita,et al.  The carbohydrate deficient glycoprotein syndrome in three Japanese children , 1992, Brain and Development.

[115]  C. Fielding,et al.  Effects of inhibitors of N-linked oligosaccharide processing on the secretion, stability, and activity of lecithin:cholesterol acyltransferase. , 1991, Biochemistry.

[116]  V. Tertov,et al.  Isolation of atherogenic modified (desialylated) low density lipoprotein from blood of atherosclerotic patients: separation from native lipoprotein by affinity chromatography. , 1990, Biochemical and biophysical research communications.

[117]  V. Tertov,et al.  Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells: discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients. , 1989, Biochemical and biophysical research communications.

[118]  M. Krieger,et al.  Expression of ApoE gene in Chinese hamster cells with a reversible defect in O-glycosylation. Glycosylation is not required for apoE secretion. , 1989, The Journal of biological chemistry.

[119]  I. Filipović Effect of inhibiting N-glycosylation on the stability and binding activity of the low density lipoprotein receptor. , 1989, The Journal of biological chemistry.

[120]  J. Taylor,et al.  Glycosylation of human apolipoprotein E. The carbohydrate attachment site is threonine 194. , 1989, The Journal of biological chemistry.

[121]  V. Zannis,et al.  Mutagenesis of the glycosylation site of human ApoCIII. O-linked glycosylation is not required for ApoCIII secretion and lipid binding. , 1988, The Journal of biological chemistry.

[122]  D. Kingsley,et al.  Use of a mutant cell line to study the kinetics and function of O-linked glycosylation of low density lipoprotein receptors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[123]  E. Eggermont,et al.  AN APPARENT HOMOZYGOUS X-LINKED DISORDER WITH CARBOHYDRATE-DEFICIENT SERUM GLYCOPROTEINS , 1987, The Lancet.

[124]  N. Hilschmann,et al.  Structural relationship of an apolipoprotein (a) phenotype (570 kDa) to plasminogen: homologous kringle domains are linked by carbohydrate-rich regions. , 1987, Biological chemistry Hoppe-Seyler.

[125]  T. Ogura,et al.  Molecular cloning of a human apoC-III variant: Thr 74----Ala 74 mutation prevents O-glycosylation. , 1987, Journal of lipid research.

[126]  E. Chen,et al.  cDNA sequence of human apolipoprotein(a) is homologous to plasminogen , 1987, Nature.

[127]  M. Kuwano,et al.  Low binding capacity and altered O-linked glycosylation of low density lipoprotein receptor in a monensin-resistant mutant of Chinese hamster ovary cells. , 1987, The Journal of biological chemistry.

[128]  M. Kuwano,et al.  Chinese hamster ovary cell mutant with defective down-regulation of low density lipoprotein receptors. , 1987, The Journal of biological chemistry.

[129]  G. Assmann,et al.  Characterization of an apolipoprotein C-III mutant by high-performance liquid chromatography and time-of-flight secondary ion mass spectrometry. , 1987, Journal of chromatography.

[130]  W. C. Breckenridge,et al.  Isolation and partial characterization of apolipoprotein (a) from human lipoprotein (a). , 1986, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[131]  A. Scanu,et al.  Physicochemical properties of apolipoprotein(a) and lipoprotein(a-) derived from the dissociation of human plasma lipoprotein (a). , 1986, The Journal of biological chemistry.

[132]  D. Kingsley,et al.  Reversible defects in O-linked glycosylation and LDL receptor expression in a UDP-Gal UDP-GalNAc 4-epimerase deficient mutant , 1986, Cell.

[133]  A. Catapano The distribution of apo C-II and apo C-III in very low density lipoproteins of normal and type IV subjects. , 1980, Atherosclerosis.

[134]  N. Takahashi Demonstration of a new amidase acting on glycopeptides. , 1977, Biochemical and biophysical research communications.

[135]  N. Swaminathan,et al.  The monosaccharide composition and sequence of the carbohydrate moiety of human serum low density lipoproteins. , 1976, Biochemistry.

[136]  A. Tall,et al.  Plasma cholesteryl ester transfer protein. , 1993, Journal of lipid research.